O'Brien Stephen Paul
SEC insider (Form 3/4/5 filer). CIK 0002064889. Principal Accounting Officer at Tvardi Therapeutics, Inc. (TVRD). 5 reported Form 4/5 transactions since Sep 2024; latest on Jan 29, 2026. Located in SUGAR LAND, TX.
Companies O'Brien Stephen Paul has filed insider reports for
- Tvardi Therapeutics, Inc. (TVRD): Officer, Principal Accounting Officer
O'Brien Stephen Paul
CIK: 0002064889
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Tvardi Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jan 29, 2026TVRD
Tvardi Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
15K shares- - Dec 16, 2025TVRD
Tvardi Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
4K shares- - Apr 17, 2025TVRD
Tvardi Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
7.2K shares- - Apr 15, 2025TVRD
Tvardi Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
11.4K shares- - Apr 15, 2025TVRD
Tvardi Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
3.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 29, 2026 | TVRD Tvardi Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 15,000 | - | - | Direct |
| Dec 16, 2025 | TVRD Tvardi Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 4,000 | - | - | Direct |
| Apr 17, 2025 | TVRD Tvardi Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 7,213 | - | - | Direct |
| Apr 15, 2025 | TVRD Tvardi Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 11,399 | - | - | Direct |
| Apr 15, 2025 | TVRD Tvardi Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 3,352 | - | - | Direct |
1-5 of 5 transactions